Integrating Advanced Technology to Decrease Vetting Time for Clinical Sites
“Because of the advance of technology platforms, H1 being one of them, we are able to decrease the time it takes for that initial vetting of our sites. And this has proven to be an efficiency gain for us in the clinical operations world.”
– Pamela Fearon, VP, Global Study Operations